Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 16201-16250 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04068454
Virtual Reality in Reeducation : Application to Shoulder Affections
NA
Active, not recruiting
50 participants
Started: Feb 1, 2019 · Completed: Aug 31, 2024
2 conditions
1 sponsor
1 location
NCT03877757
Family Planning Elevated: Initiative Evaluation
N/A
Active, not recruiting
22 participants
Started: Feb 1, 2019 · Completed: Dec 28, 2025
1 condition
1 sponsor
1 location
NCT03797157
Human Milk Fortification in Extremely Preterm Infants
PHASE2/PHASE3
Active, not recruiting
229 participants
Started: Feb 1, 2019 · Completed: Jan 31, 2029
3 conditions
6 sponsors
5 locations
NCT02683889
Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation
PHASE3
Active, not recruiting
20 participants
Started: Feb 1, 2019 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT03822312
A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy
NA
Active, not recruiting
30 participants
Started: Feb 1, 2019 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT03811821
Fecal Incontinence Treatment (FIT) Study
NA
Active, not recruiting
275 participants
Started: Feb 1, 2019 · Completed: Dec 31, 2025
2 conditions
8 sponsors
6 locations
NCT03611738
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
PHASE1
Active, not recruiting
21 participants
Started: Feb 1, 2019 · Completed: Apr 30, 2026
6 conditions
1 sponsor
2 locations
NCT03803696
Multimodal Sexual Dysfunction Intervention In HCT
NA
Active, not recruiting
230 participants
Started: Feb 1, 2019 · Completed: Dec 31, 2024
3 conditions
3 sponsors
1 location
NCT03819361
Effect of Longitudinal Sleep Monitoring on Diagnosis and Treatment Decision in Patients with Suspected Obstructive Sleep Apnea
N/A
Active, not recruiting
130 participants
Started: Feb 1, 2019 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT03847844
UCMSCs as Front-line Approach of Treatment for Patients With aGVHD
PHASE1/PHASE2
Active, not recruiting
26 participants
Started: Feb 1, 2019 · Completed: Jan 25, 2024
1 condition
2 sponsors
1 location
NCT03828825
Evaluation of the Efficacy and Safety of a Simplified Procedure for the Percutaneous Closure of the Patent Foramen Ovale
NA
Active, not recruiting
279 participants
Started: Feb 1, 2019 · Completed: Apr 30, 2027
1 condition
1 sponsor
3 locations
NCT03729557
Cardiovascular Remodeling in Living Kidney Donors With Reduced Glomerular Filtration Rate
N/A
Active, not recruiting
109 participants
Started: Feb 1, 2019 · Completed: Jan 1, 2029
1 condition
3 sponsors
1 location
NCT03820661
High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma
NA
Active, not recruiting
30 participants
Started: Feb 1, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05898191
Effect of Laser Therapy on Vaginal Tissue
NA
Active, not recruiting
15 participants
Started: Feb 1, 2019 · Completed: Mar 1, 2024
2 conditions
3 sponsors
1 location
NCT03512249
Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
PHASE2
Active, not recruiting
831 participants
Started: Jan 31, 2019 · Completed: Mar 30, 2024
1 condition
9 sponsors
6 locations
NCT03849651
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
PHASE2
Active, not recruiting
140 participants
Started: Jan 31, 2019 · Completed: Aug 7, 2025
8 conditions
1 sponsor
1 location
NCT03737981
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
PHASE3
Active, not recruiting
465 participants
Started: Jan 31, 2019 · Completed: Jun 9, 2026
2 conditions
1 sponsor
862 locations
NCT02530034
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
PHASE1
Active, not recruiting
72 participants
Started: Jan 31, 2019 · Completed: Jan 31, 2026
11 conditions
2 sponsors
4 locations
NCT03750318
Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital
NA
Active, not recruiting
39 participants
Started: Jan 31, 2019 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT03703856
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
PHASE4
Active, not recruiting
32 participants
Started: Jan 31, 2019 · Completed: Sep 1, 2025
1 condition
1 sponsor
1 location
NCT03740334
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
PHASE1
Active, not recruiting
45 participants
Started: Jan 30, 2019 · Completed: Oct 1, 2025
1 condition
2 sponsors
12 locations
NCT03732794
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
NA
Active, not recruiting
150 participants
Started: Jan 30, 2019 · Completed: Jun 30, 2026
3 conditions
1 sponsor
15 locations
NCT03861975
Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening
NA
Active, not recruiting
100 participants
Started: Jan 30, 2019 · Completed: May 30, 2026
1 condition
2 sponsors
1 location
NCT03212274
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
PHASE2
Active, not recruiting
89 participants
Started: Jan 30, 2019 · Completed: Jul 28, 2026
7 conditions
1 sponsor
51 locations
NCT03850600
Modulating Early Life Microbiome Through Dietary Intervention in Crohn's Disease
NA
Active, not recruiting
194 participants
Started: Jan 30, 2019 · Completed: Nov 30, 2027
2 conditions
3 sponsors
2 locations
NCT03841422
Evaluation of Video-assisted Instructions of Nasal Self-packing in Patients with HHT
N/A
Active, not recruiting
60 participants
Started: Jan 30, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03796962
A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
PHASE2
Active, not recruiting
325 participants
Started: Jan 30, 2019 · Completed: Oct 31, 2028
1 condition
2 sponsors
95 locations
NCT03347838
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers
PHASE2
Active, not recruiting
36 participants
Started: Jan 30, 2019 · Completed: Dec 31, 2026
4 conditions
2 sponsors
2 locations
NCT04102176
Halting Nucleoside Analogues in Chronic Hepatitis B
NA
Active, not recruiting
120 participants
Started: Jan 29, 2019 · Completed: Feb 28, 2026
1 condition
4 sponsors
1 location
NCT03284385
Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
PHASE2
Active, not recruiting
60 participants
Started: Jan 29, 2019 · Completed: Mar 1, 2026
7 conditions
1 sponsor
29 locations
NCT03614949
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
PHASE2
Active, not recruiting
21 participants
Started: Jan 29, 2019 · Completed: Oct 31, 2026
3 conditions
2 sponsors
2 locations
NCT03541850
Stereotactic Body Radiation Therapy in Treating Patients with Localized Prostate Cancer That Have Undergone Surgery
PHASE2
Active, not recruiting
92 participants
Started: Jan 29, 2019 · Completed: Nov 1, 2026
5 conditions
2 sponsors
2 locations
NCT04261712
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
PHASE2
Active, not recruiting
43 participants
Started: Jan 29, 2019 · Completed: Mar 31, 2028
1 condition
1 sponsor
21 locations
NCT03844620
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer
PHASE2
Active, not recruiting
100 participants
Started: Jan 29, 2019 · Completed: Aug 31, 2026
9 conditions
2 sponsors
1 location
NCT05334173
Gastric Bypass With Different Lengths of the Bilipancreatic Limb
NA
Active, not recruiting
94 participants
Started: Jan 29, 2019 · Completed: Sep 21, 2026
6 conditions
2 sponsors
3 locations
NCT03846219
MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)
PHASE2
Active, not recruiting
210 participants
Started: Jan 28, 2019 · Completed: Dec 31, 2029
1 condition
1 sponsor
38 locations
NCT03782636
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
PHASE2
Active, not recruiting
41 participants
Started: Jan 28, 2019 · Completed: Sep 30, 2026
1 condition
5 sponsors
5 locations
NCT03734692
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer
PHASE1/PHASE2
Active, not recruiting
24 participants
Started: Jan 28, 2019 · Completed: Jan 10, 2027
1 condition
3 sponsors
1 location
NCT03598595
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
PHASE1/PHASE2
Active, not recruiting
31 participants
Started: Jan 28, 2019 · Completed: Nov 13, 2025
2 conditions
2 sponsors
1 location
NCT03581877
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
PHASE4
Active, not recruiting
31 participants
Started: Jan 28, 2019 · Completed: Mar 19, 2025
4 conditions
1 sponsor
2 locations
NCT03582748
Neuroimaging Predictors of Bariatric Surgical Outcome
N/A
Active, not recruiting
210 participants
Started: Jan 25, 2019 · Completed: Sep 1, 2024
1 condition
2 sponsors
1 location
NCT03665051
Electrical Stimulation of Human Myocytes in Microgravity
N/A
Active, not recruiting
75 participants
Started: Jan 25, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03888651
Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers
N/A
Active, not recruiting
125 participants
Started: Jan 25, 2019 · Completed: Apr 30, 2027
1 condition
2 sponsors
1 location
NCT03747120
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
PHASE2
Active, not recruiting
138 participants
Started: Jan 25, 2019 · Completed: Dec 31, 2029
2 conditions
3 sponsors
5 locations
NCT03756896
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma
PHASE2
Active, not recruiting
29 participants
Started: Jan 25, 2019 · Completed: Jun 30, 2026
1 condition
4 sponsors
1 location
NCT03748641
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
PHASE3
Active, not recruiting
765 participants
Started: Jan 25, 2019 · Completed: Feb 27, 2027
1 condition
1 sponsor
318 locations
NCT03758638
Healthy Eating and Active Living Taught at Home (HEALTH) Dissemination & Implementation (D&I)
PHASE3
Active, not recruiting
624 participants
Started: Jan 25, 2019 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT03823209
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
NA
Active, not recruiting
500 participants
Started: Jan 24, 2019 · Completed: Dec 1, 2025
1 condition
1 sponsor
2 locations
NCT03739775
Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)
NA
Active, not recruiting
172 participants
Started: Jan 24, 2019 · Completed: Jun 1, 2026
1 condition
1 sponsor
5 locations
NCT03725436
ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors
PHASE1
Active, not recruiting
35 participants
Started: Jan 24, 2019 · Completed: Jul 26, 2027
15 conditions
2 sponsors
1 location
Previous
1
More pages
322
323
324
325
326
327
328
More pages
431
Next